Serum proteomic study on EGFR-TKIs target treatment for patients with NSCLC.
Wu X, Liang W, Hou X, Lin Z, Zhao H, Huang Y, Fang W, Zhao Y, Wu J, Yang Y, Xue C, Hu Z, Zhang J, Zhang J, Ma Y, Zhou T, Qin T, Zhang L.
Wu X, et al. Among authors: qin t.
Onco Targets Ther. 2013 Oct 21;6:1481-91. doi: 10.2147/OTT.S51887. eCollection 2013.
Onco Targets Ther. 2013.
PMID: 24204163
Free PMC article.